Immuron Financials
| IMRN Stock | USD 2.15 0.17 8.59% |
Immuron |
Understanding current and past Immuron Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Immuron's financial statements are interrelated, with each one affecting the others. For example, an increase in Immuron's assets may result in an increase in income on the income statement.
Immuron Stock Summary
Immuron competes with Tscan Therapeutics, In8bio, Phio Pharmaceuticals, Immix Biopharma, and Innate Pharma. Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, Israel, Canada, the United States, and internationally. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia. Immuron operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US45254U1016 |
| CUSIP | 45254U101 |
| Location | Australia |
| Business Address | 62 Lygon Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.immuron.com.au |
| Phone | 61 3 9824 5254 |
| Currency | USD - US Dollar |
Immuron Key Financial Ratios
| Return On Equity | -0.43 | ||||
| Return On Asset | -0.17 | ||||
| Target Price | 4.66 | ||||
| Beta | 1.17 |
Immuron Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Immuron's current stock value. Our valuation model uses many indicators to compare Immuron value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Immuron competition to find correlations between indicators driving Immuron's intrinsic value. More Info.Immuron Ltd ADR is rated third overall in return on equity category among its peers. It also is rated third overall in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Immuron's earnings, one of the primary drivers of an investment's value.Immuron Ltd ADR Systematic Risk
Immuron's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Immuron volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Immuron Ltd ADR correlated with the market. If Beta is less than 0 Immuron generally moves in the opposite direction as compared to the market. If Immuron Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Immuron Ltd ADR is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Immuron is generally in the same direction as the market. If Beta > 1 Immuron moves generally in the same direction as, but more than the movement of the benchmark.
Immuron January 21, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Immuron help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Immuron Ltd ADR. We use our internally-developed statistical techniques to arrive at the intrinsic value of Immuron Ltd ADR based on widely used predictive technical indicators. In general, we focus on analyzing Immuron Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Immuron's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.29 | |||
| Information Ratio | 0.0416 | |||
| Maximum Drawdown | 26.44 | |||
| Value At Risk | (6.22) | |||
| Potential Upside | 7.33 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuron Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immuron. If investors know Immuron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immuron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Immuron Ltd ADR is measured differently than its book value, which is the value of Immuron that is recorded on the company's balance sheet. Investors also form their own opinion of Immuron's value that differs from its market value or its book value, called intrinsic value, which is Immuron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immuron's market value can be influenced by many factors that don't directly affect Immuron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immuron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.